by Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud Mouse skin containing a basal cell carcinoma that expresses Survivin. Tumor cells in green and cells expressing Survivin in red. Credit: Adriana Sánchez-Danés An international team, co-led by Adriana Sánchez-Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud...
Tag: <span>Basal cell carcinoma</span>
Post
First-in-class histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma
by American Association for Cancer Research Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation showed signs of clinical efficacy in patients with basal cell carcinoma, according to results from a phase II clinical trial published in Clinical Cancer Research. Basal cell carcinoma (BCC) is the most common form of skin cancer and is typically treated...
Post
Topical skin cream for treatment of basal cell carcinoma shows promise as an alternative to surgery — ScienceDaily
Basal cell carcinoma (BCC), a type of skin cancer, is the most common form of human cancer. With a growing aging population, BCC rates are climbing at an alarming rate, with reported cases rising by as much as 10% per year. Rising demand makes a simple and effective treatment for BCC appealing to both practitioners...